Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cells

Molecular Carcinogenesis

Volumn 51, Issue 6, 2012, Pages 449-464

  To, Kenneth K W ^a   Yu, Le ^b   Liu, Shuwen ^b   Fu, Jianhua ^c   Cho, Chi Hin ^d  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

ABCG2; Aryl hydrocarbon receptor; Cisplatin; Esophageal squamous cell carcinoma; Multidrug resistance

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BREAST CANCER RESISTANCE PROTEIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; HEAT SHOCK PROTEIN 90 INHIBITOR; IRINOTECAN; KAEMPFEROL; SALICYLAMIDE; TANESPIMYCIN;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CIGARETTE SMOKING; DRUG RECEPTOR BINDING; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE SILENCING; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REPORTER GENE; XENOBIOTIC METABOLISM;

EID: 84859916423     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20810     Document Type: Article

References (44)

1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349: 2241-2252.
2. Yang L, Parkin DM, Li L, Chen Y. Time trends in cancer mortality in China: 1987-99. Int J Cancer 2003; 106: 771-783.
3. Hiyama T, Yoshihara M, Tanaka S, Chayama K. Genetic polymorphisms and esophageal cancer risk. Int J Cancer 2007; 121: 1643-1658.
4. Wu IC, Lu CY, Kuo FC, et al. Interaction between cigarette, alcohol and betel nut use on esophageal cancer risk in Taiwan. Eur J Clin Invest 2006; 36: 236-241.
5. Langer R, Specht K, Becker K, et al. Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma. Clin Cancer Res 2005; 11: 7462-7469.
6. Langer R, Specht K, Becker K, et al. Comparison of pretherapeutic and posttherapeutic expression levels of chemotherapy-associated genes in adenocarcinomas of the esophagus treated by 5-fluorouracil- and cisplatin-based neoadjuvant chemotherapy. Am J Clin Pathol 2007; 128: 191-197.
7. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999; 91: 1194-1210.
8. Muto H, Takizawa Y. Dioxins in cigarette smoke. Arch Environ Health 1989; 44: 171-174.
9. Lofroth G, Zebuhr Y. Polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) in mainstream and sidestream cigarette smoke. Bull Environ Contam Toxicol 1992; 48: 789-794.
10. Barouki R, Coumoul X, Fernandez-Salquero PM. The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett 2007; 581: 3608-3615.
11. Kitamura M, Kasai A. Cigarette smoke as a trigger for the dioxin receptor-mediated signaling pathway. Cancer Lett 2007; 252: 184-194.
12. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat Rev Cancer 2002; 2: 48-58.
13. Robey RW, Polgar O, Deeken J, To KW, Bates SE. ABCG2: Determining its relevance in clinical drug resistance. Cancer Metastasis Rev 2007; 26: 39-57.
14. Tsunoda S, Okumura T, Ito T, et al. ABCG2 expression is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma. Oncology 2006; 71: 251-258.
15. Ma L, Wang WP, Chow JYC, Lam SK, Cho CH. The role of polyamines in gastric mucus synthesis inhibited by cigarette smoke or its extract. Gut 2000; 47: 170-177.
16. Hu YC, Lam KY, Wan TSK, et al. Establishment and characterization of HKESC-1, a new cancer cell line from human esophageal squamous cell carcinoma. Cancer Genet Cytogenet 2000; 118: 112-120.
17. Wen J, Zheng B, Hu Y, et al. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line. Oncol Rep 2009; 22: 65-71.
18. To KK, Polgar O, Huff LM, Morisaki K, Bates SE. Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells. Mol Cancer Res 2008; 6: 151-164.
19. Yang X, Solomon S, Fraser LR, et al. Constitutive regulation of CYP1B1 by the aryl hydrocarbon receptor (AhR) in pre-malignant and malignant mammary tissue. J Cell Biochem 2008; 104: 402-417.
20. Chen Y, Lin MC, Yao H, et al. Lentivirus-mediated RNA interference targeting enhancer of Zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin. Hepatology 2007; 46: 200-208.
21. Yuan B, Latek R, Hossbach M, et al. siRNA selection server: An automated siRNA oligonucleotide prediction server. Nuclei Acids Res 2004; 32: W130-W134.
22. Robey RW, Steadman K, Polgar O, et al. Pheophorbide A is a specific probe for ABCG2 function and inhibition. Cancer Res 2004; 64: 1242-1246.
23. Skehan P, Stornet R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990; 82: 1107-1112.
24. Tan KP, Wang B, Yang M, et al. Aryl hydrocarbon receptor (AHR) is a transcriptional activator of human breast cancer resistance protein (BCRP/ABCG2). Mol Pharmacol 2010; 78: 175-185.
25. To KK, Robey R, Zhan Z, et al. Upregulation of ABCG2 by Romidepsin via the aryl hydrocarbon receptor pathway. Mol Cancer Res 2011; 9: 516-527.
26. Kuo MH, Allis CD. In vivo cross-linking and immunoprecipitation for studying dynamic protein: DNA associations in a chromatin environment. Methods 1999; 19: 425-433.
27. Hughes D, Guttenplan JB, Marcus CB, Subbaramaiah K, Dannenberg AJ. HSP90 inhibitors suppress aryl hydrocarbon receptor-mediated activation of CYP1A1 and CYP1B1 transcription and DNA adduct formation. Cancer Prev Res (PhilaPa) 2008; 1: 485-493.
28. Hu YC, Lam KY, Law S, Wong J, Srivastava G. Identification of differentially expressed genes in esophageal squamous cells carcinoma (ESCC) by cDNA expression array. Overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC. Clin Cancer Res 2001; 7: 2213-2221.
29. Takashima N, Ishiguro H, Kuwabara Y, et al. Gene expression profiling of the response of esophageal carcinoma cells to cisplatin. Dis Esophagus 2008; 21: 230-235.
30. Toshimitsu H, Hashimoto K, Tanhoku A, et al. Molecular signature linked to acquired resistance to cisplatin in esophageal cancer cells. Cancer Lett 2004; 211: 69-78.
31. Port JL, Yamaguchi K, Du B, et al. Tobacco smoke induces CYP1B1 in the aerodigestive tract. Carcinogenesis 2004; 25: 2275-2281.
32. Spira A, Beane J, Shah V, et al. Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc Natl Acad Sci USA 2004; 101: 10143-10148.
33. Ma Q, Whitlock JP, Jr. The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin. Mol Cell Biol 1996; 16: 2144-2150.
34. Singh SS, Hord NG, Perdew GH. Characterization of the activated form of the aryl hydrocarbon receptor in the nucleus of HeLa cells in the absence of exogenous ligand. Arch Biochem Biophys 1996; 329: 47-55.
35. Chang CY, Puga A. Constitutive activation of the aromatic hydrocarbon receptor. Mol Cell Biol 1998; 18: 525-535.
36. Hayashibara T, Yamada Y, Mori N, et al. Possible involvement of aryl hydrocarbon receptor (AhR) in adult T-cell leukaemia (ATL) leukemogenesis: Constitutive activation of AhR in ATL. Biochem Biophys Res Commun 2003; 300: 128-134.
37. Ito T, Tsukemo S, Suzuki N, et al. A constitutively active arylhydrocarbon receptor induces growth inhibition of Jurkat T cells through changes in the expression of genes related to apoptosis and cell cycle arrest. J Biol Chem 2004; 279: 25204-25210.
38. Spink DC, Spink BC, Cao JQ, et al. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 1998; 19: 291-298.
39. Yang X, Liu D, Murray T, et al. The aryl hydrocarbon receptor constitutively represses c-myc transcription in human mammary tumor cells. Oncogene 2005; 24: 7869-7881.
40. Shehin SE, Stephenson RO, Greenlee WF. Transcriptional regulation of the human CYP1B1 gene. Evidence for involvement of an aryl hydrocarbon receptor response element in constitutive expression. J Biol Chem 2000; 275: 6770-6776.
41. Ebert B, Seidel A, Lampen A. Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2cells and its induction by Ah-receptor agonists. Carcinogenesis 2005; 26: 1754-1763.
42. Ebert B, Seidel A, Lampen A. Phytochemicals induce breast cancer resistance protein in Caco-2cells and enhance the transport of benzo(a)pyrene-3-sulfate. Toxicol Sci 2007; 96: 227-236.
43. Puppala D, Gairola CG, Swanson HI. Identification of kaempferol as an inhibitor of cigarette smoke-induced activation of the aryl hydrocarbon receptor and cell transformation. Carcinogenesis 2007; 28: 639-647.
44. MacDonald CJ, Ciolino HP, Yeh GC. The drug salicylamide is an antagonist of the aryl hydrocarbon receptor that inhibits signal transduction induced by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Cancer Res 2004; 64: 429-434.